<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Butcher Fog | Activity</title>
	<link>https://www.catswannabecats.com/members/traymale8/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/traymale8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Butcher Fog.</description>
	<lastBuildDate>Sat, 27 Jun 2026 19:00:28 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">2a4750c2e46dd181857b75e1f418e155</guid>
				<title>Butcher Fog posted an update: Using panel data from 11 regions (9 provinces and two [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24425/</link>
				<pubDate>Sun, 08 Jun 2025 12:35:20 -0400</pubDate>

									<content:encoded><![CDATA[<p>Using panel data from 11 regions (9 provinces and two cities) in the Yangtze River Economic Belt (YREB) during 2002-2017, the regional differences in and spatial characteristics of the green efficiency of water resources along the YREB were analyzed. The undesirable outputs slacks-based measure-data envelopment analysis, Malmquist index, and&hellip;<span class="activity-read-more" id="activity-read-more-24425"><a href="https://www.catswannabecats.com/activity/p/24425/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d90a19535e247174834902df2afe7139</guid>
				<title>Butcher Fog posted an update: Ponatinib is a tyrosine kinase inhibitor (TKI) approved for [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22564/</link>
				<pubDate>Sat, 07 Jun 2025 12:43:32 -0400</pubDate>

									<content:encoded><![CDATA[<p>Ponatinib is a tyrosine kinase inhibitor (TKI) approved for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia and acute lymphoblastic leukemia. Common adverse effects of ponatinib include neutropenia, arterial thrombosis, and hypertension. We describe a 49-year-old woman who developed panniculitis after brief treatment&hellip;<span class="activity-read-more" id="activity-read-more-22564"><a href="https://www.catswannabecats.com/activity/p/22564/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1974d964a8b4aea215c4b0686e9549d1</guid>
				<title>Butcher Fog posted an update: Ponatinib is a tyrosine kinase inhibitor (TKI) approved for [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22425/</link>
				<pubDate>Sat, 07 Jun 2025 12:17:43 -0400</pubDate>

									<content:encoded><![CDATA[<p>Ponatinib is a tyrosine kinase inhibitor (TKI) approved for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia and acute lymphoblastic leukemia. Common adverse effects of ponatinib include neutropenia, arterial thrombosis, and hypertension. We describe a 49-year-old woman who developed panniculitis after brief treatment&hellip;<span class="activity-read-more" id="activity-read-more-22425"><a href="https://www.catswannabecats.com/activity/p/22425/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6e728e60b4d5b344e5be26ea69137ec4</guid>
				<title>Butcher Fog posted an update: The patients with malignant pleural mesothelioma showed a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21298/</link>
				<pubDate>Fri, 06 Jun 2025 13:24:14 -0400</pubDate>

									<content:encoded><![CDATA[<p>The patients with malignant pleural mesothelioma showed a five-fold higher expression in the APEX2, BRCA1, BRCA2, CDK7, MLH1, MLH3, MSH3, MSH4, NEIL3, PARP2, PARP3, PMS1, RAD50, RAD51, RAD51B, RAD51D, RAD52, RPA3, SMUG1, UNG, XPA, XRCC2, and XRCC4 genes, compared to the control group. Comparing malignant pleural mesothelioma with lung&hellip;<span class="activity-read-more" id="activity-read-more-21298"><a href="https://www.catswannabecats.com/activity/p/21298/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">630d7360e9deee743c39a08fff9b22f6</guid>
				<title>Butcher Fog posted an update: All rights reserved. This article is protected by copyright. [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20334/</link>
				<pubDate>Thu, 05 Jun 2025 12:39:20 -0400</pubDate>

									<content:encoded><![CDATA[<p>All rights reserved. This article is protected by copyright. All rights reserved.OBJECTIVES To identify predictors of poor overall survival (OS) among penile squamous-cell carcinoma (pSCC) patients with clinical inguinal lymphadenopathy (cN+) in order to define the best candidate for neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS Using an&hellip;<span class="activity-read-more" id="activity-read-more-20334"><a href="https://www.catswannabecats.com/activity/p/20334/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2c7df62b31baeaf0fb7f457c13033809</guid>
				<title>Butcher Fog posted an update: Breast cancer is the most common malignant tumor in women [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19032/</link>
				<pubDate>Wed, 04 Jun 2025 12:14:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>Breast cancer is the most common malignant tumor in women globally. Currently, due to limited data, there are no international guidelines for addressing the management of a large group of patients during infectious disease pandemics. Coronavirus disease 2019 (COVID-19), declared as a pandemic by the World Health Organization (WHO), has rapidly&hellip;<span class="activity-read-more" id="activity-read-more-19032"><a href="https://www.catswannabecats.com/activity/p/19032/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">eb4ab4051082d82dbab43a366f8c2430</guid>
				<title>Butcher Fog posted an update: SUMMARYGram-negative bacteremia is a devastating public [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4256/</link>
				<pubDate>Sat, 31 May 2025 12:26:09 -0400</pubDate>

									<content:encoded><![CDATA[<p>SUMMARYGram-negative bacteremia is a devastating public health threat, with high mortality in vulnerable populations and significant costs to the global economy. Concerningly, rates of both Gram-negative bacteremia and antimicrobial resistance in the causative species are increasing. Gram-negative bacteremia develops in three phases. First,&hellip;<span class="activity-read-more" id="activity-read-more-4256"><a href="https://www.catswannabecats.com/activity/p/4256/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fcde1446dfa2607181ba9c506b0818c1</guid>
				<title>Butcher Fog became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4115/</link>
				<pubDate>Sat, 31 May 2025 12:10:26 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>